COLL vs TXN · P/E 17, rev $181.9M vs P/E 52, rev $17.68B
Collegium Pharmaceutical Inc (COLL) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the COLL and TXN stock pages for the full models.
Not investment advice.